Daily Schedule
Home
Saturday, November 9, 2024
Times and topics subject to change. All times in Central Standard Time.
| Time | Session/Topic | Location/Presenter |
|---|---|---|
| 6:00 a.m. - 6:30 p.m. | Attendee Registration | Longhorn Marble Foyer |
| 6:00 a.m. - 12:30 p.m. | Exhibitor Registration | Longhorn Marble Foyer |
| 6:00 a.m. - 6:45 a.m. | AAHKS Committee Breakfast For AAHKS Committee Members only | Grapevine Ballroom A |
| 6:00 a.m. - 7:30 a.m. | Breakfast for All Attendees | Exhibit Hall/Learning Center Longhorn Exhibition Hall C–F |
| 7:00 a.m. - 2:00 p.m. | Exhibit Hall/Learning Center Open | Exhibit Hall/Learning Center Longhorn Exhibition Hall C–F |
| 7:00 a.m. - 2:00 p.m. | Scientific Poster Exhibition Open | Exhibit Hall/Learning Center Longhorn Exhibition Hall C–F |
| 9:00 a.m. - 5:00 p.m. | AAHKS Shop Open | Center Pre-Function (Level 3) |
| 6:55 a.m. - 6:27 p.m. | AAHKS General Session | Texas Ballroom |
| 6:55 a.m. - 7:00 a.m. | Program Chair’s Welcome to the 2024 Annual Meeting | Jonathan M. Vigdorchik, MD |
| 7:00 a.m. - 7:34 a.m. | Session Two: Perioperative Optimization | Moderators: Michael J. Taunton, MD Claudette M. Lajam, MD |
| 7:00 a.m. | Paper #11 GLP-1 Receptor Agonist Utilization at the Time of THA for Patients with Morbid Obesity | Gwo-Chin Lee, MD New York, NY |
| 7:06 a.m. | Paper #12 Optimal Timing for Cessation of GLP-1 Agonist before Elective TJA | Christopher T. Holland, MD, MS Memphis, TN |
| 7:12 a.m. | Paper #13 GLP-1 Receptor Agonist Mediated Weight Loss Improves Outcomes After TKA | Vishal Hegde, MD Baltimore, MD |
| 7:18 a.m. | Paper #14 GLP-1 Receptor Agonists Decrease Postoperative Complications Following TKA | Joshua S. Bingham, MD Phoenix, AZ |
| 7:24 a.m. | Discussion | All Faculty |
| 7:34 a.m. - 8:34 a.m. | Symposium III: Patient Preoperative Optimization: How to Do It and How to Be Paid for the Work | Moderator: Kevin B. Fricka, MD |
| 8:34 a.m. – 8:54 a.m. | Break | Exhibit Hall/Learning Center Longhorn Exhibition Hall C–F |
| 8:54 a.m. - 9:56 a.m. | Session Three: Revision TKA | Moderators: Matthew P. Abdel, MD Elizabeth B. Gausden, MD, MPH |
| 8:54 a.m. | Paper #15 Comparison of Survivorship of Distal Femoral Replacements by Fixation Method | Yale A. Fillingham, MD Philadelphia, PA |
| 9:00 a.m. | Paper #16 Prior Canal Instrumentation Is a Major Risk Factor for Fixation Failure after DFR | Andrew J. Hughes, MD, FRCS New York, NY |
| 9:06 a.m. | Paper #17 Outcomes Following Distal Femur Replacement: A Multi-Institutional Retrospective Review | David C. Landy, MD, PhD Memphis, TN |
| 9:12 a.m. | Paper #18 575 Rotating-Hinge TKAs: Surprisingly Low Rates of Aseptic Loosening | E. Bailey Terhune, MD Rochester, MN |
| 9:18 a.m. | Discussion | All Faculty |
| 9:28 a.m. | Paper #19 Mid-Term Clinical Outcomes in Revision TKA for Flexion Instability | Luke R. Lovro, MD Indianapolis, IN |
| 9:34 a.m. | Paper #20 Does UKA Failure Mode Impact Conversion TKA Outcomes? | Robert A. Sershon, MD Alexandria, Virgina |
| 9:40 a.m. | Paper #21 Intraosseous Vancomycin Reduces the Rate of PJI Following Aseptic Revision TKA | Colin A. McNamara, MD, MBA Miami, FL |
| 9:46 a.m. | Discussion | All Faculty |
| 9:56 a.m. | American Joint Replacement Registry (AJRR) Update | James I. Huddleston III, MD |
| 10:01 a.m. – 10:46 a.m. | Symposium IV: Practice Norms in Primary Hip and Knee Arthroplasty: What Is Everyone Else Doing? | Moderator: Daniel J. Berry, MD |
| 10:46 a.m. – 11:48 a.m. | Session Four: Infection | Moderators: Antonia F. Chen, MD MBA Bryan D. Springer, MD |
| 10:46 a.m. | Paper #22 Autoclave Efficacy on Contaminated Orthopedic Cement | Alberto V. Carli, MD, MSc New York, NY |
| 10:52 a.m. | Paper #23 Extended Oral Antibiotics Is Protective Against Repeated PJI | Kenneth R. Urish, MD, PhD Pittsburgh, PA |
| 10:58 a.m. | Paper #24 DAIR for Acute PJI: Results of 133 Primary THAs at Extended Follow-Up of 7 Years | Matthew P. Abdel, MD Rochester, MN |
| 11:04 a.m. | Discussion | All Faculty |
| 11:14 a.m. | Paper #25 One-Stage vs. Two-Stage Treatment for PJI: A Prospective, Randomized Trial | Thomas K. Fehring, MD Charlotte, NC |
| 11:20 a.m. | Paper #26 Only 20% of TKA PJIs Meet Published Eligibility Criteria for One-Stage Exchange | Nicholas A. Bedard, MD Rochester, MN |
| 11:26 a.m. | Paper #27 Sobering Outcomes of Two-Stage Revision for PJI Among Patients with Revision TKA Components | Nathanael D. Heckmann, MD Los Angeles, CA |
| 11:32 a.m. | Paper #28 Repeat Two-Stage Exchange Arthroplasty for Recurrent PJI of the Hip: Sobering Results | Aaron R. Owen, MD Rochester, MN |
| 11:38 a.m. | Discussion | All Faculty |
| 11:48 a.m. – 12:48 p.m. | Lunch for all attendees | Exhibit Hall/Learning Center Longhorn Exhibition Hall C–F |
| 11:48 a.m. - 12:48 p.m. | Arthroplasty Today (AT) Editorial Board Lunch | Fort Worth 5-6 |
| 12:48 p.m. – 1:48 p.m. | Keynote Session - Damon West | Texas Ballroom |
| 1:48 p.m. – 2:48 p.m. | Symposium V: Management of PJI: No Longer a “One Size Fits All” Two-Stage Exchange | Moderator: Yale A. Fillingham, MD |
| 2:48 p.m. – 3:08 p.m. | Break | Texas Ballroom Foyer |
| 3:08 p.m. | AAHKS Presidential Award Presented to: Gregory J. Golladay, MD | Presented by: James I. Huddleston III, MD |
| 3:13 p.m. | Lawrence D. Dorr, MD, Humanitarian Award Presented to: Douglas A. Dennis, MD | Presented by: Julius K. Oni, MD |
| 3:18 p.m. | FARE Grant Awards | Presented by: Ran Schwarzkopf, MD, MSc |
| 3:23 p.m. | James A. Rand Young Investigator's Award: “What is the Safest and Most Effective Dose of IV Dexamethasone in TKA? A Multicenter Prospective RCT” Presented to: Charles P. Hannon, MD, MBA (Rochester, MN) | Presented by: Matthew P. Abdel, MD |
| 3:29 p.m. | AAHKS Surgical Techniques & Technologies Award: "Synovial Fluid Metal Ions: Diagnostic Markers for Aseptic Loosening in Cemented TKA” Presented to: J. Ryan Martin, MD (Nashville, TN) | Presented by: James A. Browne, MD |
| 3:35 p.m. | AAHKS Clinical Research Award: “Intraosseous Regional Diclofenac for Post-Op Pain Management in TKA” Presented to: Simon W. Young, MD (Auckland, New Zealand) | Presented by: Ran Schwarzkopf, MD, MSc |
| 3:41 p.m. | Discussion | All Faculty |
| 3:51 p.m. – 5:27 p.m. | Session Five: Primary THA | Moderators: Mark J. Spangehl, MD Anna R. Cohen-Rosenblum, MD, MSc |
| 3:51 p.m. | Paper #29 Impact of Stem Designs in Periprosthetic Fracture Risk after Arthroplasty for Femoral Neck Fractures | Panayiotis Megaloikonomos, MD Vancouver, Canada |
| 3:57 p.m. | Paper #30 Cementless Hemiarthroplasty Complication Risk Does Not Support Contemporary Utilization Patterns | Lucas A. Anderson, MD Salt Lake City, UT |
| 4:03 p.m. | Paper #31 Is Bone Cement Implantation Syndrome Really Caused by Cement? A Review Using Bradford-Hill Criteria | James A. Browne, MD Charlottesville, VA |
| 4:09 p.m. | Paper #32 Cementless Collared Metadiaphyseal-Filling Stems vs. Cemented Fixation for THA | Harpal S. Khanuja, MD Baltimore, MD |
| 4:25 p.m. | Paper #33 Pre-Operative Surgical Prep Is Not Effective at Eliminating C. Acnes Prior to THA | Jason M. Jennings, MD Denver, CO |
| 4:31 p.m. | Paper #34 Risk Factors for Wound Complications in Direct Anterior THA: A 10-Year Analysis | Joshua C. Rozell, MD New York, NY |
| 4:37 p.m. | Paper #35 Three-Month Infection after Vancomycin and Iodine Irrigation in High-Risk THA and TKA: A Multicenter RCT | Ran Schwarzkopf, MD, MSc New York, NY |
| 4:43 p.m. | Paper #36 Rapidly Progressive Osteoarthritis after Hip Corticosteroid Injection: You Must Exclude Infection | Adam J. Taylor, MD Torrence, CA |
| 4:49 p.m. | Discussion | All Faculty |
| 4:59 p.m. | Paper #37 Risk Factors for Dislocation After Direct Anterior THA | Murillo Adrados, MD Roanoke, VA |
| 5:05 p.m. | Paper #38 Dislocated Dual-Mobility Hips: High Risk for Fail Closed Reduction with Increased Risk for Revision | Janyne L. Mallender, DO Phoenix, AZ |
| 5:11 p.m. | Paper #39 Formal Physical Therapy Clearance is Not Necessary for Safe Home Discharge after Primary TJA | Sumon Nandi, MD, MBA Baltimore, MD |
| 5:17 p.m. | Discussion | All Faculty |
| 5:27 p.m. – 6:27 p.m. | Symposium VI: The Complex Primary THA: A Roadmap to a Successful Outcome | Moderator: Ran Schwarzkopf, MD, MSc |
| 6:27 p.m. | Adjourn |
